DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Sai Life Sciences Limited — Press Release

NSE 4 hrs ago·5 Nov 2026, 6:42 pm

SAI Life Sciences

Sai Life Sciences has announced that it will release its financial results for the recently completed quarter. The company has informed the stock exchanges that the formal press release, detailing its earnings, is scheduled for publication on November 05, 2026.

Investors will be keenly watching this update to gauge the company's current performance and future outlook. The results will provide crucial insights into the firm's operational health, revenue growth, and profitability, which are key factors for retail investors assessing the stock's value.

Market participants should monitor the release closely for any commentary on business conditions and guidance. This information will be vital for making informed decisions regarding the stock's short-term and long-term potential.